Institute of Pharmacology and Therapeutics, Faculty of Medicine and IBMC, University of Porto, Porto, Portugal.
Purinergic Signal. 2008 Sep;4(3):267-85. doi: 10.1007/s11302-008-9096-0. Epub 2008 Apr 29.
There is considerable evidence that purines are vasoactive molecules involved in the regulation of blood flow. Adenosine is a well known vasodilator that also acts as a modulator of the response to other vasoactive substances. Adenosine exerts its effects by interacting with adenosine receptors. These are metabotropic G-protein coupled receptors and include four subtypes, A(1), A(2A), A(2B) and A(3). Adenosine triphosphate (ATP) is a co-transmitter in vascular neuroeffector junctions and is known to activate two distinct types of P2 receptors, P2X (ionotropic) and P2Y (metabotropic). ATP can exert either vasoconstrictive or vasorelaxant effects, depending on the P2 receptor subtype involved. Splanchnic vascular beds are of particular interest, as they receive a large fraction of the cardiac output. This review focus on purinergic receptors role in the splanchnic vasomotor control. Here, we give an overview on the distribution and diversity of effects of purinergic receptors in splanchnic vessels. Pre- and post-junctional receptormediated responses are summarized. Attention is also given to the interactions between purinergic receptors and other receptors in the splanchnic circulation.
有相当多的证据表明嘌呤类物质是血管活性分子,参与调节血流。腺苷是一种众所周知的血管扩张剂,也可以作为其他血管活性物质反应的调节剂。腺苷通过与腺苷受体相互作用发挥其作用。这些是代谢型 G 蛋白偶联受体,包括四个亚型,A(1)、A(2A)、A(2B) 和 A(3)。三磷酸腺苷 (ATP) 是血管神经效应器接头的共递质,已知可激活两种不同类型的 P2 受体,P2X(离子型)和 P2Y(代谢型)。ATP 可以产生血管收缩或血管舒张作用,具体取决于涉及的 P2 受体亚型。内脏血管床特别有趣,因为它们接收了很大一部分心输出量。这篇综述重点介绍嘌呤能受体在内脏血管舒缩控制中的作用。在这里,我们概述了嘌呤能受体在内脏血管中的分布和作用多样性。总结了前、后突触受体介导的反应。还注意到了嘌呤能受体与内脏循环中其他受体之间的相互作用。